+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Parexel International Corp - Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development, and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in the Americas, Asia Pacific, and EMEA countries across the world. Parexel is headquartered in Newton, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Jun 16, 2022: Parexel expands patient access to clinical trials through new community alliance network
Feb 23, 2022: Parexel and n-Lorem Foundation partner to support development of new investigational therapies for nano-rare patients
Feb 07, 2022: Parexel, Medidata expand collaboration to boost decentralised trial delivery
Feb 04, 2022: Parexel extends strategic partnership with Medidata to enhance delivery of decentralized clinical trials
Aug 02, 2021: Parexel’s Peyton Howell and Sofia Baig named to 2021 PharmaVOICE 100

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Parexel International Corp - Key Facts
  • Parexel International Corp - Key Employees
  • Parexel International Corp - Key Employee Biographies
  • Parexel International Corp - Major Products and Services
  • Parexel International Corp - History
  • Parexel International Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Parexel International Corp - Business Description
  • Parexel International Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Parexel International Corp - Strengths
  • Parexel International Corp - Weaknesses
  • Parexel International Corp - Opportunities
  • Parexel International Corp - Threats
  • Parexel International Corp - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Parexel International Corp, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jun 16, 2022: Parexel expands patient access to clinical trials through new community alliance network
  • Feb 23, 2022: Parexel and n-Lorem Foundation partner to support development of new investigational therapies for nano-rare patients
  • Feb 07, 2022: Parexel, Medidata expand collaboration to boost decentralised trial delivery
  • Feb 04, 2022: Parexel extends strategic partnership with Medidata to enhance delivery of decentralized clinical trials
  • Aug 02, 2021: Parexel’s Peyton Howell and Sofia Baig named to 2021 PharmaVOICE 100
  • Jul 28, 2021: Parexel announces innovative patient centric partnership with cancer hospital chinese academy of medical sciences
  • Jul 22, 2021: Parexel announces innovative partnership with Rare Disease Foundation in China
  • Jul 07, 2021: Parexel Expands Asia/Pacific capability through enhanced clinical trial supplies and logistics offering
  • May 04, 2021: Parexel achieves top rankings in industry across multiple attributes in ISR CRO phase II-III benchmarking report
  • Apr 16, 2021: Parexel and Veeva Systems collaborate to advance clinical trial technology
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Parexel International Corp, Key Facts
  • Parexel International Corp, Key Employees
  • Parexel International Corp, Key Employee Biographies
  • Parexel International Corp, Major Products and Services
  • Parexel International Corp, History
  • Parexel International Corp, Other Locations
  • Parexel International Corp, Subsidiaries
  • Parexel International Corp, Key Competitors
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Parexel International Corp, Recent Deals Summary
List of Figures
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cellero LLC
  • Aptuit LLC
  • IQVIA Holdings Inc
  • ICON Plc
  • Syneos Health NC LLC
  • Veeva Systems Inc
  • Laboratory Corp of America Holdings
  • Vaso Corp
  • Labcorp Drug Development
  • Quintiles Transnational Corp
  • Frontage Holdings Corp
  • Genesis Biotechnology Group LLC
  • Pharmaceutical Product Development LLC
  • Worldwide Clinical Trials Drug Development Solutions Inc
  • Patheon NV